Related Experiment Video
Updated: Aug 11, 2026
08:32
Dissecting Innate Immune Signaling in Viral Evasion of Cytokine Production
Published on: March 2, 2014
Limitin: an interferon-like cytokine without myeloerythroid suppressive properties
K Oritani1, P W Kincade, Y Tomiyama
1Department of Internal Medicine and Molecular Science, Graduate School of Medicine, Osaka University, Suita City, Japan. oritani@imed2.med.osaka-u.ac.jp
Journal of Molecular Medicine (Berlin, Germany)
|June 21, 2001
Summary
Limitin, a novel interferon-like cytokine, inhibits lympho-hematopoietic cell growth and possesses antiviral and immunomodulatory functions. It uniquely spares myeloid and erythroid progenitors, suggesting therapeutic potential.
Area of Science:
- Immunology
- Molecular Biology
- Cytokine Research
Background:
- Interferons (IFNs) are crucial cytokines with diverse roles in immunity and cell regulation.
- The type I IFN family includes IFN-alpha, IFN-beta, IFN-omega, and IFN-tau, each with specific functions.
- Understanding novel IFNs is key to deciphering complex immune networks and developing new therapies.
Purpose of the Study:
- To identify and characterize a novel cytokine, limitin, with potential interferon-like activity.
- To elucidate the cellular targets and biological functions of limitin.
- To assess the potential of limitin as a therapeutic agent.
Main Methods:
- Cloning and characterization of the limitin gene and protein.
- Assays to evaluate limitin's effects on lympho-hematopoietic cell growth and survival.
- Analysis of limitin's binding to IFN receptors and induction of signaling pathways (e.g., IFN regulatory factor-1).
- In vitro and in vivo studies on immune cell proliferation and function, including T lymphocytes, NK cells, and stromal cells.
- Assessment of antiviral activity and effects on myeloid and erythroid progenitors.
Main Results:
- Limitin, a 182 amino acid protein, shares sequence identity with type I IFNs and binds to IFN-alpha/beta receptors.
- Limitin induces IFN regulatory factor-1, confirming its classification as a type I IFN.
- Limitin inhibits B lymphopoiesis in vitro and in vivo.
- Limitin modulates proliferation and function of T lymphocytes, NK cells, and bone marrow stromal cells.
- Limitin exhibits antiviral activity.
- Crucially, limitin does not affect normal myeloid and erythroid progenitors, distinguishing it from other IFNs.
Conclusions:
- Limitin is a novel, multifunctional type I interferon with significant immunomodulatory and antiviral activities.
- Its unique lack of myelosuppressive effects makes it a promising candidate for therapeutic development.
- Limitin plays a role in the complex IFN network and warrants further investigation for its therapeutic applications.
More Related Videos
Related Concept Videos
01:52Eukaryotic Transcription Inhibitors
Certain biochemical processes, such as embryonic development and cell growth regulation, depend on the repression of specific genes. DNA binding proteins known as eukaryotic transcription inhibitors regulate the repression of gene expression in eukaryotes. The presence of these inhibitors at the required location and time in the cell is triggered by the presence of hormones and additional signals from other cells.
Eukaryotic transcription inhibitors usually contain two distinct domains, a DNA...
Eukaryotic transcription inhibitors usually contain two distinct domains, a DNA...
01:30Inhibitors of Viral Protein Synthesis
Protein synthesis is indispensable for viral replication, as viruses lack the cellular machinery required for this process and must hijack the host's translational apparatus. In response, host cells deploy a critical innate immune defense involving interferons, specialized cytokines that play a central role in inhibiting viral propagation.Upon viral detection, infected cells release interferons that bind to receptors on adjacent uninfected cells, activating the JAK-STAT signaling pathway and...